Safety of drugs during pregnancy and breastfeeding in cystic fibrosis patients.

Details

Serval ID
serval:BIB_C8F67FDB86FD
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Title
Safety of drugs during pregnancy and breastfeeding in cystic fibrosis patients.
Journal
Respiration; international review of thoracic diseases
Author(s)
Panchaud A., Di Paolo E.R., Koutsokera A., Winterfeld U., Weisskopf E., Baud D., Sauty A., Csajka C.
ISSN
1423-0356 (Electronic)
ISSN-L
0025-7931
Publication state
Published
Issued date
2016
Peer-reviewed
Oui
Volume
91
Number
4
Pages
333-348
Language
english
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Abstract
Health management of cystic fibrosis (CF) patients should be maximized during pregnancy and breastfeeding because of its significant impact on the maternal and newborn outcomes. Thus, numerous drugs will have to be continued during pregnancy and lactation. Most of the drugs representing CF treatment lines cross the placenta or are excreted into human milk. Research addressing the risks and benefits of drugs used in CF patients during pregnancy and lactation is often incomplete or challenged by limited methodology, which often leads to conflicting or inconclusive results. Yet, potential treatment benefits for CF pregnant patients most often outbalance potential risks for the unborn child.

Keywords
Breast Feeding, Cystic Fibrosis/drug therapy, Drug-Related Side Effects and Adverse Reactions, Female, Fetus/drug effects, Humans, Pregnancy, Pregnancy Complications/drug therapy, Teratogens
Pubmed
Web of science
Open Access
Yes
Create date
10/06/2016 16:53
Last modification date
01/10/2019 11:23
Usage data